New challenges and best practices for the laboratory monitoring of factor VIII and factor IX replacement-Reference-Cited by-同舟云学术

New challenges and best practices for the laboratory monitoring of factor VIII and factor IX replacement

Published:2018-05 Issue: Volume:40 Page:21-29
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hem

Author:

Van den Bossche D.¹,Peerlinck K.²³⁴,Jacquemin M.¹²³⁴^ORCID

Affiliation:

1. Department of Laboratory Medicine; University Hospitals of Leuven; Leuven Belgium

2. Center for Molecular and Vascular Biology; University of Leuven; Leuven Belgium

3. Department of Vascular Medicine and Hemostasis; University Hospitals Leuven; Leuven Belgium

4. National Coordinating Hemophilia Center; University Hospitals Leuven; Leuven Belgium

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijlh.12813/fullpdf

Reference39 articles.

1. Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIII;Reding;J Thromb Haemost,2017

2. Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A;Tiede;J Thromb Haemost,2013

3. BAX, 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation;Turecek;Hämostaseologie,2012

4. Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials;Tiede;Haemophilia,2017

5. Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients;Powell;Blood,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of one‐stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII‐Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single‐centre, real‐world experience of surgery;Haemophilia;2023-12-27

2. A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis;Thrombosis and Haemostasis;2023-02-09

3. A Review of Factor VIII and Factor IX Assay Methods for Monitoring Extended Half-Life Products in Hemophilia A and B;Methods in Molecular Biology;2023

4. Guidance for establishing a factor VIII testing protocol for the myriad of factor VIII products;International Journal of Laboratory Hematology;2021-11-16

5. Current therapeutic approaches in the management of hemophilia—a consensus view by the Romanian Society of Hematology;Annals of Translational Medicine;2021-07